• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-29a 通过靶向 HDAC4 促进间充质干细胞的成骨分化。

MiR-29a promotes osteogenic differentiation of mesenchymal stem cells via targeting HDAC4.

机构信息

Department of Neurosurgery, Beijing Chao-Yang Hospital, Beijing, P.R. China.

出版信息

Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3318-3326. doi: 10.26355/eurrev_201806_15151.

DOI:10.26355/eurrev_201806_15151
PMID:29917181
Abstract

OBJECTIVE

To investigate the role of miR-29a in regulating the differentiation mesenchymal stem cells into osteoblasts.

MATERIALS AND METHODS

For the first step, the changes of expression of miR-29a during the process of mesenchymal stem cells (MSCs) differentiation into osteoblast were detected. Then, we infected the MSCs with mimics or inhibitors of miR-29a to explore the roles of miR-29a in the differentiation. Further, the prediction and verification of the possible target genes of miR-29a were achieved by bioinformatics analysis and luciferase reporter assay.

RESULTS

MiR-29a was up-regulated during the process of MSCs differentiation into osteoblasts. Overexpression or inhibition of miR-29a using mimics or inhibitors had no significant effect on cell proliferation. Furthermore, the differentiation was enhanced when miR-29a was artificially overexpressed in vitro, whereas silencing of miR-29a attenuated this process. It was evidenced by alkaline phosphatase (ALP) staining, matrix mineralization, and increased expression of osteoblast-specific genes. Furthermore, we determined that the gene HDAC4 might be a direct target of miR-29a.

CONCLUSIONS

In the current study, miR-29a promotes osteogenesis via suppressing HDAC4, indicating that targeting miR-29a may be feasible in the management of osteoporosis.

摘要

目的

研究 miR-29a 在调控间充质干细胞向成骨细胞分化中的作用。

材料与方法

首先,检测 miR-29a 在间充质干细胞(MSCs)向成骨细胞分化过程中的表达变化。然后,我们用 miR-29a 的模拟物或抑制剂感染 MSCs,以探讨 miR-29a 在分化中的作用。进一步通过生物信息学分析和荧光素酶报告基因实验预测和验证 miR-29a 的可能靶基因。

结果

miR-29a 在 MSCs 向成骨细胞分化过程中上调。使用模拟物或抑制剂过表达或抑制 miR-29a 对细胞增殖没有显著影响。此外,体外人工过表达 miR-29a 增强了分化,而沉默 miR-29a 则减弱了这一过程。碱性磷酸酶(ALP)染色、基质矿化和骨细胞特异性基因表达增加证实了这一点。此外,我们确定 HDAC4 基因可能是 miR-29a 的直接靶基因。

结论

在本研究中,miR-29a 通过抑制 HDAC4 促进成骨作用,表明靶向 miR-29a 可能在骨质疏松症的治疗中是可行的。

相似文献

1
MiR-29a promotes osteogenic differentiation of mesenchymal stem cells via targeting HDAC4.miR-29a 通过靶向 HDAC4 促进间充质干细胞的成骨分化。
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3318-3326. doi: 10.26355/eurrev_201806_15151.
2
Subchondral mesenchymal stem cells from osteoarthritic knees display high osteogenic differentiation capacity through microRNA-29a regulation of HDAC4.骨关节炎膝关节软骨下间充质干细胞通过 microRNA-29a 调控 HDAC4 表现出高成骨分化能力。
J Mol Med (Berl). 2017 Dec;95(12):1327-1340. doi: 10.1007/s00109-017-1583-8. Epub 2017 Sep 7.
3
MiR-214 Attenuates Osteogenic Differentiation of Mesenchymal Stem Cells via Targeting FGFR1.微小RNA-214通过靶向成纤维细胞生长因子受体1减弱间充质干细胞的成骨分化
Cell Physiol Biochem. 2016;38(2):809-20. doi: 10.1159/000443036. Epub 2016 Feb 15.
4
MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs.miRNA-19a-3p 通过靶向 HDAC4 促进 hMSCs 的成骨分化来缓解骨质疏松症的进展。
Biochem Biophys Res Commun. 2019 Aug 27;516(3):666-672. doi: 10.1016/j.bbrc.2019.06.083. Epub 2019 Jun 24.
5
Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression.miR-22 的上调通过抑制 HDAC6 蛋白表达促进人脂肪组织来源间充质干细胞的成骨分化并抑制其成脂分化。
Stem Cells Dev. 2012 Sep 1;21(13):2531-40. doi: 10.1089/scd.2012.0014. Epub 2012 Apr 2.
6
MiR-374b promotes osteogenic differentiation of MSCs by degrading PTEN and promoting fracture healing.miR-374b 通过降解 PTEN 促进 MSC 的成骨分化,从而促进骨折愈合。
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3303-3310. doi: 10.26355/eurrev_201806_15149.
7
MicroRNA-29a ameliorates glucocorticoid-induced suppression of osteoblast differentiation by regulating β-catenin acetylation.microRNA-29a 通过调控β-连环蛋白乙酰化改善糖皮质激素诱导的成骨细胞分化抑制
Bone. 2013 Dec;57(2):468-75. doi: 10.1016/j.bone.2013.09.019. Epub 2013 Oct 2.
8
MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis.MiR-27a对绝经后骨质疏松症中间充质干细胞从成骨分化向脂肪生成分化的转变至关重要。
Cell Physiol Biochem. 2016;39(1):253-65. doi: 10.1159/000445621. Epub 2016 Jun 24.
9
MiR-125b Regulates the Osteogenic Differentiation of Human Mesenchymal Stem Cells by Targeting BMPR1b.微小RNA-125b通过靶向骨形态发生蛋白受体1b调控人间充质干细胞的成骨分化
Cell Physiol Biochem. 2017;41(2):530-542. doi: 10.1159/000457013. Epub 2017 Jan 31.
10
miR-16-2* Interferes with WNT5A to Regulate Osteogenesis of Mesenchymal Stem Cells.miR-16-2* 通过干扰WNT5A来调节间充质干细胞的成骨作用。
Cell Physiol Biochem. 2018;51(3):1087-1102. doi: 10.1159/000495489. Epub 2018 Nov 26.

引用本文的文献

1
Circulating and extracellular vesicle-derived microRNAs as biomarkers in bone-related diseases.循环和细胞外囊泡衍生的 microRNAs 作为与骨相关疾病的生物标志物。
Front Endocrinol (Lausanne). 2023 May 24;14:1168898. doi: 10.3389/fendo.2023.1168898. eCollection 2023.
2
MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease.微小RNA:慢性肾脏病中骨脆性的新兴生物标志物和治疗靶点
Clin Kidney J. 2022 Oct 7;16(3):408-421. doi: 10.1093/ckj/sfac219. eCollection 2023 Mar.
3
circ_0003204 regulates the osteogenic differentiation of human adipose-derived stem cells via miR-370-3p/HDAC4 axis.
circ_0003204 通过 miR-370-3p/HDAC4 轴调控人脂肪源性干细胞的成骨分化。
Int J Oral Sci. 2022 Jun 21;14(1):30. doi: 10.1038/s41368-022-00184-2.
4
Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro.在体外条件下,缺氧环境中 BM-MSC 治疗 ALL 细胞中与增殖相关的基因的表达受表观遗传因素的影响。
Med Oncol. 2022 May 18;39(5):88. doi: 10.1007/s12032-022-01671-6.
5
The Regulation of Collagen Processing by miRNAs in Disease and Possible Implications for Bone Turnover.miRNAs 在疾病中对胶原处理的调控及其对骨转换的可能影响。
Int J Mol Sci. 2021 Dec 22;23(1):91. doi: 10.3390/ijms23010091.
6
miRNAs Related to Different Processes of Fracture Healing: An Integrative Overview.与骨折愈合不同过程相关的微小RNA:综合概述
Front Surg. 2021 Nov 19;8:786564. doi: 10.3389/fsurg.2021.786564. eCollection 2021.
7
Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions.循环微RNA与多发性骨髓瘤和骨骼溶骨性病变相关。
Cancers (Basel). 2021 Oct 20;13(21):5258. doi: 10.3390/cancers13215258.
8
Micro-RNAs: A safety net to protect hematopoietic stem cell self-renewal.微小 RNA:保护造血干细胞自我更新的安全网。
Wiley Interdiscip Rev RNA. 2022 May;13(3):e1693. doi: 10.1002/wrna.1693. Epub 2021 Sep 16.
9
The p53/miR-145a Axis Promotes Cellular Senescence and Inhibits Osteogenic Differentiation by Targeting Cbfb in Mesenchymal Stem Cells.p53/miR-145a轴通过靶向间充质干细胞中的Cbfb促进细胞衰老并抑制成骨分化。
Front Endocrinol (Lausanne). 2021 Jan 11;11:609186. doi: 10.3389/fendo.2020.609186. eCollection 2020.
10
The role of microRNAs in bone development.微小 RNA 在骨发育中的作用。
Bone. 2021 Feb;143:115760. doi: 10.1016/j.bone.2020.115760. Epub 2020 Nov 19.